Pro Share Advisors LLC Relay Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$42.5 Billion
Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 42,200 shares of RLAY stock, worth $172,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,200

Previous 26,708 58.01%

Holding current value

$172,598

Previous $189,000 8.47%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$4.12 - $6.8 $63,827 - $105,345	15,492 Added 58.01%	42,200 $173,000
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $36,289 - $55,395	5,825 Added 27.89%	26,708 $189,000
Q2 2024 Aug 13, 2024	SELL	$5.9 - $8.02 $31,452 - $42,754	-5,331 Reduced 20.34%	20,883 $136,000
Q1 2024 May 08, 2024	BUY	$7.5 - $12.07 $25,455 - $40,965	3,394 Added 14.87%	26,214 $217,000
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $18,673 - $35,668	3,107 Added 15.76%	22,820 $251,000
Q3 2023 Nov 13, 2023	BUY	$8.24 - $12.97 $840 - $1,322	102 Added 0.52%	19,713 $165,000
Q2 2023 Aug 10, 2023	BUY	$9.99 - $18.27 $11,768 - $21,522	1,178 Added 6.39%	19,611 $246,000
Q1 2023 May 11, 2023	SELL	$15.0 - $22.76 $37,755 - $57,286	-2,517 Reduced 12.01%	18,433 $303,000
Q4 2022 Feb 02, 2023	BUY	$14.16 - $24.02 $47,506 - $80,587	3,355 Added 19.07%	20,950 $312,000
Q3 2022 Nov 04, 2022	BUY	$18.07 - $31.37 $9,721 - $16,877	538 Added 3.15%	17,595 $394,000
Q2 2022 Aug 01, 2022	SELL	$13.31 - $34.88 $96,763 - $253,577	-7,270 Reduced 29.88%	17,057 $286,000
Q1 2022 May 10, 2022	SELL	$20.26 - $32.36 $125,064 - $199,758	-6,173 Reduced 20.24%	24,327 $728,000
Q4 2021 Feb 08, 2022	BUY	$26.0 - $37.03 $78,130 - $111,275	3,005 Added 10.93%	30,500 $936,000
Q3 2021 Nov 12, 2021	SELL	$29.75 - $37.99 $127,657 - $163,015	-4,291 Reduced 13.5%	27,495 $867,000
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $194,700 - $270,385	7,080 Added 28.66%	31,786 $1.16 Million
Q1 2021 May 14, 2021	BUY	$32.52 - $61.53 $120,063 - $227,168	3,692 Added 17.57%	24,706 $854,000
Q4 2020 Feb 09, 2021	BUY	$35.51 - $54.03 $746,207 - $1.14 Million	21,014 New	21,014 $873,000

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $492M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Relay Therapeutics, Inc. Transaction History